Thermo Fisher Scientific (TMO)

Investing Cash Flow

-$12.03B

TTM · Period ending: · USD

TMO logo

TMO Investing Cash Flow

Latest reported-$12.03B
TMO TTM Cash from Investing (-$76.00M → -$12.03B)
High-resolution chart · PNG

TMO investing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Some observations are unavailable. The chart shows available values; missing observations are not treated as zero.

Thermo Fisher Scientific Investing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingInvesting Cash Flow (USD)
-12,029,000,000
-12,481,000,000
-4,047,000,000
-4,918,000,000
-4,373,000,000
-4,338,000,000
-5,841,000,000
-6,237,000,000
-3,840,000,000
-4,030,000,000
-5,142,000,000
-5,291,000,000
-4,655,000,000
-4,631,000,000
-2,159,000,000
-20,326,000,000
-20,397,000,000
-20,604,000,000
-21,932,000,000
-3,866,000,000
-3,615,000,000
-3,248,000,000
-1,510,000,000
-1,223,000,000
-1,056,000,000
-1,566,000,000
-1,487,000,000
-1,869,000,000
-1,839,000,000
-1,255,000,000
-1,253,000,000
-815,400,000
-7,615,700,000
-7,526,100,000
-7,729,000,000
-7,533,700,000
-4,761,400,000
-4,774,700,000
-5,532,100,000
-5,955,400,000
-1,866,100,000
-1,832,400,000
-1,087,400,000
-702,000,000
-177,900,000
-109,100,000
-11,782,700,000
-11,726,700,000
-12,205,000,000
-12,264,100,000
-263,300,000
-252,700,000
-1,153,500,000
-1,326,700,000
-1,325,800,000
-1,339,200,000
-4,081,000,000
-5,119,500,000
-5,142,200,000
-5,221,700,000
-1,834,300,000
-669,900,000
-858,900,000
-1,259,300,000
-1,001,400,000
-1,041,700,000
-829,500,000
-427,000,000
-521,000,000
-459,100,000
-450,000,000
-750,000,000
-700,000,000
-613,500,000
-586,000,000
150,584,000
214,186,000
249,995,000
283,447,000
-74,450,000
-7,071,000
-754,210,000
-753,480,000
-703,817,000
-624,728,000
23,051,000
34,153,000
-18,247,000
-26,876,000
222,040,000
378,790,000
576,447,000
581,816,000
470,988,000
508,479,000
499,922,000
385,945,000
556,335,000
176,156,000
74,122,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.